SUMMARY Two hundred and forty four men with non-gonococcal urethritis (NGU) took part in a trial of minocycline. Chlamydiae were isolated from 34%, ureaplasmas from 47 -I/, and Mycoplasma hominis from 10'2%. These micro-organisms were isolated least often from mm suffering their third or more attack of NGU, and men in this group failed most often to respond to minocycline. Irrespective of the micro-organisms isolated originally or the number of previous attacks, the failure rate (10%) for men receiving minocycline for 10 days was significantly less than for those receiving this antibiotic for one or two days. More than half of the men suffering third attacks from whom micro-organisms were not isolated failed to respond to these short regimens. One of the lowest failure rates (4%) after short term treatment, however, was seen in men experiencing first attacks who yielded only ureaplasmas with or without M hominis, which indicates the importance of ureaplasmas in this group of patients. Chlamydiae were not reisolated from any patient after treatment, irrespective of its duration, and the only ureaplasmas that were reisolated were from nine patients who carried tetracycline resistant strains. Reasons for the absence of chlamydiae and ureaplasmas in the presence of disease and the need to look for other microorganisms as a cause of NGU are discussed among other issues raised by these results.
Introduction
Many studies have attempted to establish the cause of non-gonococcal urethritis (NGU).' Genital strains of Chlamydia trachomatis organisms (chlamydiae) are generally accepted as causing up to 50/o of cases of NGU,2 and Ureaplasma urealyticum organisms (ureaplasmas) may cause a smaller, ill defined, proportion of cases, 3 though the carriage of ureaplasmas in some healthy men has always created a difficulty in assessing the role of these organisms in disease. Neither chlamydiae nor ureaplasmas are isolated from some patients, and other tetracycline sensitive organisms are probably implicated, particularly as some of the patients who are free from chlamydiae and ureaplasmas respond to tetracycline treatment. 4 Indeed, the most widely prescribed antibiotics for treating NGU are the tetracyclines, to which chlamydiae and (usually) ureaplasmas are sensitive. In a previous study we showed that a seven day course of the semisynthetic tetracycline, minocycline, was more effective than a placebo in controlling the disease and that chlamydia negative, ureaplasma positive patients were clinically more responsive to the antibiotic than to the placebo, which suggested a role for the ureaplasmas.4 Even longer treatment has been advocated,5 but the effect of shorter treatment with tetracyclines has been studied rarely.67 In the study reported here we compare one, two, and 10 day minocycline treatment regimens, assessing the effects both clinically and microbiologically. The We tested the sensitivity of ureaplasmas to minocycline and erythromycin as described previously.9
STATISTICAL ANALYSIS
We applied x2 analysis or multiple regression in the logit scale analysis to the data. The results were considered to be significant if p < 0 05.
Results

ISOLATION RATES FOR VARIOUS MICRO-ORGANISMS
We included in the trial 113 men who attended clinic A and 131 who attended clinic B. Table I shows the occurrence of chlamydiae, ureaplasmas, and M hominis in these patients at their first visit. Chlamydiae were isolated from 407o of patients in clinic A and from 29% of patients in clinic B, an overall rate of 34%. Ureaplasmas were isolated from 
42 (5) 34 (6) 3 (1) 4 (2) 62 (13) 17 (1) group.bmj.com on April 9, 2017 -Published by http://sti.bmj.com/ Downloaded from D Taylor-Robinson, R T Evans, E D Coufalik, and J K Oates treatment, chlamydiae were not isolated from any patient at follow up visits to the clinics. This microbiological response was seen also for Mhominis and ureaplasmas, except in the case of nine patients from whom tetracycline resistant ureaplasma strains were recovered. The minimum inhibitory concentration of minocycline ranged from 0 3 to 40 mg/l. All of the strains were sensitive, however, to 0 08 mg/l erythromycin. Only one of the tetracycline resistant strains was isolated from a patient with persistent urethritis.
Discussion
The overall isolation rates for chlamydiae, ureaplasmas, and M hominis in this study are in keeping with those of other studies that we have conducted on patients with NGU.4 10-2Mhominiswas isolated rarely and, apart from one occasion, always in conjunction with the two other micro-organisms. For these reasons it is difficult to make comments about its role in disease. Against this background, however, several points are of interest, particularly in relation to chlamydiae and ureaplasmas. First, these microorganisms, and M hominis too, were isolated most often from patients who were allegedly experiencing their first attack of NGU. The failure to recover them as often in subsequent attacks could mean that different micro-organisms are responsible or that chlamydiae and ureaplasmas, though initiating these episodes, disappear more rapidly than they do in the first attack ("immune clearance") and fail to be detected. Both explanations seem plausible but the latter does not, of course, account for the failure to recover chlamydiae, ureaplasmas, or M hominis from at least a quarter of patients suffering a first attack of NGU. Could this "no micro-organism" gap in reality be filled by chlamydiae or ureaplasmas? It is possible that some alleged first attacks of NGU are in fact second or even subsequent episodes accounted for by these micro-organisms, which have been removed rapidly by "immune clearance". It seems unlikely, however, that this is the full explanation. It might also be argued that chlamydial and ureaplasmal isolation techniques of greater sensitivity could narrow the "no micro-organism" gap. This seems to be unlikely, however, as use of the monoclonal antibody technique for detecting chlamydiae directly in smears'3 indicates that for these organisms, at least, currently available culture techniques are sufficiently sensitive to detect all viable organisms in the urethra. Of course, not all ureaplasmas appear to be pathogenic and it is, indeed, an assumption that chlamydiae recovered from patients with NGU are in every case responsible for the disease. Even without this caveat, however, it seems that there are sufficient reasons for looking for other micro-organisms as a cause of NGU. Whether Bacteroides ureolyticus ' 4 One explanation for the discrepancy between the absence of organisms and the presence of disease would be the existence of other causative microorganisms that are eliminated only by a 10 day course of treatment. On the other hand, chlamydiae and ureaplasmas may only appear to have been eliminated by a short course of treatment and may, in fact, still be present and capable of causing disease. This seems feasible in the case of chlamydiae where a short course of minocycline may be insufficient to kill all intracellular organisms. Ureaplasmas, however, unless taken up by inflammatory cells, remain extracellular and are therefore more likely to be affected by short course treatment. Indeed, the best response to one or two days of minocycline treatment was seen in patients who possessed only ureaplasmas, with or without M hominis, and who ostensibly were experiencing their first attack of NGU: only one of 24 failed to respond, perhaps a further indication of the aetiological role of ureaplasmas in this group of patients.
These reflections on short course treatment raise two possibilities. The first is that it may be feasible to detect by rapid methods patients who are suffering 22 group.bmj.com on April 9, 2017 -Published by http://sti.bmj.com/ Downloaded from Effects of short term treatment of non-gonococcal urethritis with minocycline first attacks and are infected only by ureaplasmas and to treat them successfully with a short course of tetracycline. The second is that short term tetracycline treatment of patients with gonorrhoea (when chlamydiae often exist only in small numbers if at all) may prevent post gonococcal urethritis as effectively as a longer course of treatment. The validity or otherwise of these suggestions needs testing under appropriate clinical trial conditions.
